A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-10-01
著者
-
Quinn David
University Of Southern California - Norris Cancer Center
-
Quinn David
University Of Southern California Norris Cancer Center
-
Frankel Paul
City Of Hope Comprehensive Cancer Center
-
SHEK Derek
University of California Davis Cancer Center
-
LONGMATE Jeff
Veterans' Administration of Northern California, Mather
-
MARGOLIN Kim
University of Washington Cancer Center
-
TWARDOWSKI Przemyslaw
City of Hope Comprehensive Cancer Center
-
GANDARA David
University of California Davis Cancer Center
-
PAN Chong-Xian
University of California Davis Cancer Center
-
LARA Primo
University of California Davis Cancer Center
-
Longmate Jeff
Veterans' Administration Of Northern California Mather
関連論文
- PD2-2 The Role of Molecular Targeting Therapy for Metastatic Renal Cell Cancer : Working Toward Individual Treatment : Overview for Sorafenib
- A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma